Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 20th, 2023
Lil Wayne’s $20M Lawsuit Against Former Attorney Knocked Down
Litigation Partner John B. Harris is quoted on a recent ruling by the New York state appeals court that Lil Wayne cannot move forward with his $20 million lawsuit against his former longtime lawyer, Ronald Sweeney. John is quoted saying, “We’re pleased that the appellate court rejected Lil Wayne’s cynical attempt to avoid paying Ronald Sweeney for the work that Mr. Sweeney did for him. Mr. Sweeney will vigorously pursue his claims for payment and require Lil Wayne to appear in court to answer for his actions.”
The news was covered by various media outlets including AllHipHop, HipHopDX, Law360, The New York Law Journal, and Yahoo News. Along with John, Khasim Lockhart and Edward H. Rosenthal were part of the Frankfurt Kurnit team representing Ronald Sweeney.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
